$CAMP

2 stories mentioning CAMPUpdated just now

Every FINWIRES story that references CAMP, newest first.

JPMorgan Upgrades CAMP4 Therapeutics to Overweight From Neutral, Adjusts PT to $9 From $5

CAMP4 Therapeutics (CAMP) has an average rating of buy and mean price target of $8.36, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CAMP

Research6d ago

Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target

Camp4 Therapeutics (CAMP) has an average rating of buy and mean price target of $7.79, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CAMP

Track with the FINWIRES app suite

FolioX

Track CAMP in your portfolio

WheelAI

Analyze CAMP options with the wheel strategy

StockInsider

See market sentiment on CAMP